Diabetes

  1. 03 Oct 2012  |  South Asia, Middle East & North Africa

    Overview of the Diabetes Therapeutics Market in India

    Diabetes, an Apparent Epidemic in India: Opportunities for Pharmaceutical Companies

    This research service presents an overview of the diabetes therapeutic market in India. It quantifies the market size and provides growth forecasts of the market from 2010 to 2016. It provides an in-depth analysis of key treatment challenges of diabetes management, market drivers and restraints, and how they affect the market dynamics during the fo...

    $4,950.00

    Special Price $3,712.50 save 25 %

  2. This research service presents a marketed and pipeline analysis of the U.S. type 2 diabetes mellitus market. According to the 2011 National Diabetes Fact Sheet, 25.8 million children and adults (or 8.3 percent of the population) in the United States suffer from diabetes. Type 2 diabetes mellitus is the most common form of diabetes; approximately 90...

    $1,500.00

    Special Price $1,125.00 save 25 %

  3. 11 Sep 2011  |  Europe

    European Diabetes Therapeutics Market

    European Diabetes Therapeutics Market - How Far Would it Go:New Classes of Drugs to Emerge by 2014

    The research study aims to thoroughly assess and analyse the diabetes therapeutics market, market and technology trends, in European countries and provide strategic recommendations for the success of the market participants. Diabetes is the fastest growing market in the pharmaceutical industry. This study is focussed on two segments Insulin and Non...

    $4,950.00

    Special Price $3,712.50 save 25 %

  4. 19 Aug 2011  |  North America

    2011 U.S. Diabetes Injection Pens' Features

    U.S. Diabetes Injection Pens' Features

    A majority of type 2 diabetics currently use Lantus SoloSTAR Pen. Most of them use prefilled injection pens that are entirely disposable. These pens are more convenient to use for most patients with busy lifestyles, as they come pre-filled with insulin/medication. Easy push-button injection, transparent cartridge, and a window showing injection is ...

    $10,000.00

    Special Price $7,500.00 save 25 %

  5. 14 Mar 2011  |  North America

    2010 U.S. Type 2 Diabetes Patients' Choice: Awareness, Usage, and Preferences of Injection Pens

    2010 U.S. Type 2 Diabetes Patients' Choice: Awareness, Usage, and Preferences of Injection Pens

    Type 2 diabetes is the most common form of diabetes. It is a chronic disease marked by high levels of glucose in the blood. The primary goal to treat type 2 diabetes is diet and exercise. However, if diet and exercise does not help maintain normal glucose levels, physicians may prescribe medication. A sample size of 1,002 adult type 2 diabetes p...

    $10,000.00

    Special Price $7,500.00 save 25 %

  6. This study encompasses feedback provided by U.S. diabetes patients on aspects of drug delivery and drug treatment for diabetes, enabling interested stakeholders to gain insight into current and future trends. Data was presented for the general objective point questions as well as analysis by disease subtype where applicable. Patient feedback about ...

    $4,950.00

    Special Price $3,712.50 save 25 %

  7. This study encompasses feedback provided by U.S. physicians who treat diabetes on aspects of drug delivery and drug treatment for diabetes, enabling interested stakeholders to gain insight into current and future trends. Analysis includes issues such as awareness, usage, preferences, influencing criteria, patient compliance, desired delivery types ...

    $4,950.00

    Special Price $3,712.50 save 25 %

  8. 04 Jun 2009  |  North America

    Global Diabetes Market

     

    This research services details the market drivers, restraints, challenges, revenue forecasts of the insulin and the no-insulin market segments of the global diabetes market. It also deals with regional analysis of the US, Europe, Japan and rest of the world markets.

    $4,950.00

    Special Price $3,712.50 save 25 %

  9. 31 Dec 2008  |  Europe

    European Diabetes Diagnostics Market

     

    This strategic analysis service provides a detailed analysis of the European diabetes diagnostics market. An in-depth analysis of marketing parameters (revenues, forecasts, geographic trends and market share) coupled with competitive factors and strategies for sustained market prevalence are reported.

    $4,950.00

    Special Price $3,712.50 save 25 %

  10. This research service aims to provide an update on the epidemiology of T2 diabetes, current diagnostic and treatment practices, as well as market landscape in terms of major participants and future trends. It covers the diabetes therapeutics market in Australia.

    $4,950.00

    Special Price $3,712.50 save 25 %